Permeability of 5-fluorouracil and prodrugs in Caco-2 cell monolayers.

被引:31
作者
Buur, A
Trier, L
Magnusson, C
Artursson, P
机构
[1] UNIV UPPSALA,BMC,DEPT PHARMACEUT,S-75123 UPPSALA,SWEDEN
[2] ROYAL DANISH SCH PHARM,DEPT PHARMACEUT CHEM,DK-2100 COPENHAGEN,DENMARK
关键词
5-fluorouracil; Caco-2; monolayers; prodrugs; toxicity; permeability; drug absorption;
D O I
10.1016/0378-5173(95)04331-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The toxicity and permeability of 5-fluorouracil (5FU) and 13 5FU prodrugs was investigated in Caco-2 monolayers grown on permeable supports. Only one of the prodrugs (VII) was toxic to the cell monolayers at 1 x 10(-4) M, as assessed by an increased permeability of the cell monolayers to the hydrophilic probe C-14-mannitol. The monolayer integrity was restored after a 4-fold reduction in the concentration of this prodrug. The permeabilities of 5FU and prodrugs increased roughly with the apparent partition coefficients (P-octanol-buffer) (r = 0.74). Attempts to correlate the permeabilities with other single physicochemical parameters such as hydrogen-bonding capacity and solubility resulted in poorer correlations. A slightly better relationship was obtained when the permeability was correlated with the two physicochemical parameters (P-octanol-buffer) and aqueous solubility by multiple linear regression analysis (r = 0.81). The ranking of the permeabilities of four of the compounds previously studied in rabbit colon and rectum was comparable in the cell monolayers and in the intestinal segments. These results indicate that Caco-2 monolayers can be used to predict drug absorption, not only of conventional drugs but also of small prodrugs such as those used here.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 28 条
[1]  
ALMERSJO EE, 1980, ACTA PHARMACOL TOX, V46, P326
[2]   SOLUBILITY OF NONELECTROLYTES IN POLAR-SOLVENTS .5. ESTIMATION OF SOLUBILITY OF ALIPHATIC MONOFUNCTIONAL COMPOUNDS IN WATER USING A MOLECULAR SURFACE-AREA APPROACH [J].
AMIDON, GL ;
YALKOWSKY, SH ;
ANIK, ST ;
VALVANI, SC .
JOURNAL OF PHYSICAL CHEMISTRY, 1975, 79 (21) :2239-2246
[3]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .7. EFFECTS OF PHARMACEUTICAL SURFACTANT EXCIPIENTS AND BILE-ACIDS ON TRANSEPITHELIAL PERMEABILITY IN MONOLAYERS OF HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ANDERBERG, EK ;
NYSTROM, C ;
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (09) :879-887
[4]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[5]   SELECTIVE PARACELLULAR PERMEABILITY IN 2 MODELS OF INTESTINAL-ABSORPTION - CULTURED MONOLAYERS OF HUMAN INTESTINAL EPITHELIAL-CELLS AND RAT INTESTINAL SEGMENTS [J].
ARTURSSON, P ;
UNGELL, AL ;
LOFROTH, JE .
PHARMACEUTICAL RESEARCH, 1993, 10 (08) :1123-1129
[6]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[7]   PENETRATION OF 5-FLUOROURACIL AND PRODRUGS ACROSS THE INTESTINE OF THE ALBINO RABBIT - EVIDENCE FOR SHIFT IN ABSORPTION SITE FROM THE UPPER TO THE LOWER REGION OF THE GASTROINTESTINAL-TRACT BY PRODRUGS [J].
BUUR, A ;
YAMAMOTO, A ;
LEE, VHL .
JOURNAL OF CONTROLLED RELEASE, 1990, 14 (01) :43-51
[8]   PRODRUGS OF 5-FLUOROURACIL .5. 1-ALKOXYCARBONYL DERIVATIVES AS POTENTIAL PRODRUG FORMS FOR IMPROVED RECTAL OR ORAL DELIVERY OF 5-FLUOROURACIL [J].
BUUR, A ;
BUNDGAARD, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (05) :522-527
[9]   PRODRUGS OF 5-FLUOROURACIL .1. HYDROLYSIS KINETICS AND PHYSICOCHEMICAL PROPERTIES OF VARIOUS N-ACYL DERIVATIVES OF 5-FLUOROURACIL [J].
BUUR, A ;
BUNDGAARD, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 21 (03) :349-364
[10]   PRODRUGS AS DRUG DELIVERY SYSTEMS .37. PRODRUGS OF 5-FLUOROURACIL .4. HYDROLYSIS KINETICS, BIOACTIVATION AND PHYSICOCHEMICAL PROPERTIES OF VARIOUS N-ACYLOXYMETHYL DERIVATIVES OF 5-FLUOROURACIL [J].
BUUR, A ;
BUNDGAARD, H ;
FALCH, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 24 (01) :43-60